FDA expands approval of breast cancer drug Kisqali to earlier stage patients
- Posted on September 17, 2024
- By Bing News
- 2 Views
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said.
